dm+d
31009911000001106
Articles
Assigning stability to Zerbaxa (ceftolozane/tazobactam) in elastomeric infusers
16 November 2022Assessment of the degradation profile and toxicity data for Zerbaxa is available for its use in Outpatient Parenteral Antimicrobial Therapy (OPAT) services
Refrigerated Storage
Zerbaxa Merck Sharp & Dohme Limited
Merck Sharp & Dohme Limited
Zerbaxa
Concentrate for solution for infusion, 1g/0.5g
Contact MSD in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.
21 February 2022
London MI Service